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Abstract
Background Cell transfection requires cationic DNA complexes and
heparan sulfate proteoglycans (HSPGs) at the cell surface. Syndecans are
transmembrane HSPGs that are ubiquitously expressed on adherent cells.
Their polyanionic heparan sulfate moieties are bound at the distal end of
their ectodomain, thus facilitating interaction with large cationic particles.
Methods We propose a model for cell entry involving syndecans as receptors
for the DNA complexes by comparing transfection with bacteria uptake and
using drug inhibition experiments along with confocal microscopy.
Results When combined with results from the literature, our data suggest
the following sequence of events: after initial particle binding, gradual
electrostatic zippering of the plasma membrane onto the particle is sustained
by lateral diffusion of syndecan molecules that cluster into cholesterol-rich
rafts. Clustering in turn triggers PKC activity and linker protein-mediated
actin binding to the cytoplasmic tail of the syndecans. Resulting tension fibers
and a growing network of cortical actin may then pull the particle into the
cell.
Conclusions Diversion of integrin- and syndecan-mediated cell adhesion
processes for particle engulfment appears to be widely exploited by animals
(chylomicrons), by pathogens (bacteria, viruses) and, as suggested here, by
non-viral vectors. Copyright  2004 John Wiley & Sons, Ltd.
Keywords transfection; cell entry; invasion; cholesterol; raft
Introduction
Delivery of genes to the nucleus of eukaryotic cells is a complex multistage
process [1]. In contrast to viral infection, transfection mediated by synthetic
cationic compounds is poorly understood. Nearly a million exogeneous DNA
molecules can be found in a transfected cell [2,3], hence tracking the
intracellular fate of the few molecules that will reach the nucleus is like
looking for a needle in a haystack. However, the large number of molecules
that enter cells also highlights the fact that the receptor for the DNA complexes
must be abundant at the cell surface. This observation, combined with that
showing the receptor to be ubiquitously expressed, but only on adherent
cells [2], has focused attention on the involvement of adhesion molecules in
cell entry. As efficient transfection also requires the condensed DNA particles
to bear a cationic surface [4], it was inferred that anionic proteoglycans
were potential receptors [2]. Direct evidence for the involvement of heparan
sulfate proteoglycans (HSPGs) in transfection was obtained soon
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after [5–7], but, unfortunately, the demonstration
was not followed up. Indeed, a global view of the
various functions of the different classes of cell-surface
HSPGs has emerged only recently. Perlecans are cell-
surface-absorbed HSPGs and the GPI-anchored glypicans
are essentially expressed during development. Only
syndecans are integral transmembrane proteins and
present on all adherent cells where they cooperate with
integrins, hence the most probable candidate receptors.
In this study, we have used the actual view of the role of
syndecans in adhesion to address the mechanism of cell
entry of non-viral vectors.
HSPGs (presumably syndecans) represent anchors for
the interaction of many pathogens with their host cell
surface [8]. They have been shown to be involved
in cellular binding/entry of viruses, such as HSV [9],
AAV [10] and CMV [11], protozoan parasites [12] and
pathogenic bacteria [13,14]. Following initial binding
to HSPGs, most of these pathogens are internalized.
The mechanism of internalization appears to depend
solely, at least in some systems (e.g., epithelial cells),
on clustering (ligation) of HSPGs [15,16]. A situation in
which a single HSPG-binding function alone is sufficient
to trigger membrane engulfment has been demonstrated
using a model of antibody-coated beads, known to ligate
specifically heparan sulfate chains. HSPG-ligating beads
were shown to trigger actin-mediated phagocytic uptake
into HeLa cells by essentially the same mechanism as
microbial invasion [15–18].
Positively charged DNA complexes could also trigger
ligation of anionic HSPGs since a typical 100-nm
complex can bind many HSPG molecules. In order to
test this hypothesis, we chose the cationic polymer
polyethylenimine (PEI) to condense DNA, as PEI is among
the most efficient and popular compounds for delivery of
DNA into animal cells. Since the molecular interactions
underlying HSPG-dependent phagocytosis in epithelial
cells are well defined, we compared this process with
PEI-mediated transfection of HeLa cells. Here we report
close similarities in the cellular characteristics of both
processes and propose that a model [15] for HSPG-
dependent phagocytosis involving the actin cytoskeleton
may be valid for transfection as well.
Materials and methods
Reagents
The metabolic inhibitors, staurosporine and 2-hydro-
xypropyl-β-cyclodextrin, as well as heparin, were pur-
chased from Sigma (Saint-Quentin, France). Branched
25-kDa polyethylenimine (PEI) was purchased from
Fluka (Saint-Quentin, France). The fluorescent DNA-
intercalator YOYO-1 was purchased from Molecular
Probes (Eugene, OR, USA). FluoR-labeled PEI (Jet-PEI-
FluoR) was obtained from Polyplus-transfection (Illkirch,
France). A monoclonal anti-β-actin (clone AC-15) conju-
gated to FITC was purchased from Sigma.
Cells
HeLa human cervix epitheloid carcinoma cells (provided
by L. Monaco, Istituto San Raffaele, Milano, Italy) were
grown in MEM with Earle’s salt (PolyLabo, Strasbourg,
France). Cell culture media were supplemented with
10% fetal calf serum (GIBCO BRL, Gaithersburg, MD,
USA.), 2 mM L-glutamine, penicillin (100 units/ml),
and streptomycin (100 µg/ml; GIBCO BRL). Cells were
maintained at 37 ◦C in a 5% CO2 humidified air
atmosphere.
Cell transfection in the presence of
metabolic inhibitors
HeLa cells (5–6 × 104 cells per well) were seeded in 24-
multiwell tissue culture plates 1 day before transfection.
Inhibitors were added to the cells at the indicated
concentrations 0.5–1 h prior to transfection. DNA (pCMV-
Luc) and branched 25-kDa PEI were mixed at a ratio
of 10 amine/phosphate (N/P) in 150 mM NaCl (2 µg
DNA/100 µl NaCl solution), left for 10 min at room
temperature and the resulting PEI/DNA complexes were
added to the cells in the absence of serum at an amount
of 1 µg DNA/well. Two transfection protocols were then
designed to avoid possible deleterious effects caused by a
prolonged exposure to the drug: for transfections in the
presence of staurosporine, the plates were centrifuged
(300 g, 5 min), immediately after addition of complexes,
in order to bring the complexes quickly in contact
with the cells [19]. After centrifugation, the cells were
incubated for 90 min at 37 ◦C and then washed with
heparin (2 mg/ml PBS, 30 min) to remove the residual
adhering transfection material. The cells were then
supplemented with fresh, drug-free medium containing
10% FCS and cultured for an additional 24 h at 37 ◦C, until
ultimately lysed and tested for luciferase gene expression.
Altogether, the drug was present for the first 2 h of
transfection. Drug-induced toxicity was assessed by the
MTT test which showed metabolic activity to remain
unaffected within 15% up to 100 nM staurosporine;
preincubation with 200 nM drug led to a 50% decrease
in activity. The amounts of total cell proteins recovered
followed similar trends.
An additional protocol was developed for transfections
involving 2-hydroxypropyl-β-cyclodextrin, according to
which the drug was kept present in all media for the
entire transfection time. By the end of the experiment,
however, the cells were round and only loosely attached
to the substratum. To avoid cell loss as a result of repeated
washes at the end of the transfection, the transfections
were carried out in serum-free medium. At the end of
the transfection, the lysis reagent was added directly
to the transfection medium, thus avoiding the washing
steps. The total amount of cell protein recovered was not
affected by the presence of cyclodextrin.
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Luciferase assay
Luciferase gene expression was measured by a lumi-
nescence assay. Transfected cells were lysed using lysis
reagent 5× (Promega), which was applied, either at work-
ing concentration (1×) on top of cells after washing or
diluted directly into the transfection medium (see above).
After 30 min incubation at room temperature, the cell
lysate was harvested, vortex-mixed gently and centrifuged
for 5 min at 17 500 g at 4 ◦C. Then, 20 µl of the super-
natant were diluted into 100 µl luciferase reaction buffer
(Promega) and the luminescence was integrated over
10 s (Mediators, Vienna, Austria); 15 µl of the super-
natant were used to assay for the amount of protein (BCA
assay; Pierce). Experiments were carried out in triplicate.
Results are expressed as relative light units per mg of cell
protein ± standard deviation.
FACS analysis
Plasmid DNA and the fluorescent DNA-intercalator YOYO-
1 were mixed at a ratio of 1 YOYO-1 molecule per
75 base pairs (0.8 mole %) and were allowed to
complex for 10 min at room temperature. YOYO-1-labeled
DNA was then used to prepare PEI/DNA complexes
exactly as outlined in the experimental procedures
above. HeLa cells were transfected with the YOYO-
1-labeled fluorescent PEI/DNA complexes. Transfection
was performed according to the experimental procedures
and was stopped after 1 h by heparin wash (2 mg/ml
PBS, 30 min). Confocal analysis in similar conditions
showed no bound complexes. The cells were washed
with PBS, trypsinized, fixed by incubation with 3%
paraformaldehyde for 20 min, and finally suspended in
1 ml PBS with 1% BSA. Fluorescent cells were detected
by flow cytometry with a FACStar Plus cell sorter and
data were analysed with CELLQuest (Beckton Dickinson,
Pont de Claix, France). Experiments were performed in
triplicate using 10 000 cells prior to moderate gating.
Confocal laser scanning microscopy
Fluorescent images of transfected HeLa cells were
obtained with a confocal laser scanning microscope (a
Bio-Rad MRC 1024ES confocal microscope coupled to
a NIKON Eclipse TE 300 inverted microscope). Digital
image recording was performed using LaserSharp 2.3
software (Bio-Rad). HeLa cells (4–5 × 104 cells, reaching
ca. 60% confluence during the experiment) were plated
1 day before transfection on 4-well Lab-Tek chambered
coverglass (Nalge Nunc International, Napperville, IL,
USA). To view the binding and internalization of
PEI/DNA complexes, cells were transfected with YOYO-
1-labeled fluorescent PEI/DNA complexes as outlined
above. Measurements were performed directly on the
Lab-Tek dishes, on living cells at room temperature. For
double staining of actin and PEI/DNA complexes, 10% Jet-
PEI-FluoR-labeled PEI/DNA complexes were introduced
into HeLa cells grown on Lab-Tek chamber slides. Cells
were fixed after 3 h transfection and stained by anti-β-
actin conjugated to FITC according to the Sigma staining
protocol. After fixation and staining, the cell monolayers
were inverted onto thin glass slides and analyzed under
the microscope. Complexes appeared generally larger on
fixed cells than on live cells. This may be an artefact due
to reticulation of polyamines by formaldehyde.
Results and discussion
Syndecans have been shown to serve as receptors for
HSPG-dependent bacterial invasion of HeLa cells [16].
The primary cellular function of the syndecan family
(four members) is to act as adhesion molecules; they bind
extracellular matrix proteins and contribute to coordi-
nating the cellular processes of migration, adhesion and
cytoskeleton organization [20]. They have been shown to
be involved in focal adhesion and stress fiber formation
together with members of the integrin family [21–23,27].
The intracellular domains of all syndecans interact with
several PDZ (post-synaptic density disc-large zo-1 [25])
domain-containing proteins [21]. These are proteins that
link a number of binding partners through multiple PDZ
domains and other protein binding motifs. They are often
involved in clustering of transmembrane receptors and
linking them to the actin cytoskeleton and to signal-
ing molecules. Thus, the consequence of syndecan liga-
tion by consecutive binding sites on extracellular matrix
molecules is formation of large multimolecular signaling
complexes at the membrane, syndecan serving as the orga-
nizing center, for adhesion and growth factor-dependent
signaling [21]. Clustering of syndecans by a pathogen
seems to induce a similar response [16–18]. Indeed,
a syndecan construct lacking the short C-terminal motif
required for binding of the PDZ domain completely blocks
HSPG-dependent bacterial uptake in HeLa cells [16].
It has been proposed that the so-called zippering
of invasive bacteria to form tightly fitted and size-
adjusted phagosomes is in fact the result of a serial
recruitment of receptors and structural proteins. The basic
mechanism being that a series of contacts is made over
the entire surface of the microorganism until the cell
surface wraps around the bacterium [24]. Protein kinase
C is also recruited into the large multiprotein complex
forming at the adhesion point where it regulates the
associations [21,26]. Previous studies have underlined
the involvement of PKC in HSPG-dependent phagocytosis
in HeLa cells [15–17]. In the present study, we examined
the possibility that the cellular receptors of PEI/DNA
complexes might also be subjected to PKC regulation. To
test if PKC might have a role in internalization of PEI/DNA
complexes, we treated HeLa cells with staurosporine
[15,17] and tested the effects of this PKC inhibitor
on transfection efficiency using a luciferase assay. As
shown in Figure 1, staurosporine inhibited transfection
in a concentration-dependent manner. The effects were
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Figure 1. Effect of staurosporine on transfection efficiency.
HeLa cells were transfected in the presence of staurosporine
with pCMVLuc/PEI complexes (N/P = 10). The drug and the
complexes were washed-off after 90 min. Luciferase activity
(relative light units (RLU)/mg cell protein± SD) was measured
after 24 h. A substantial decrease in luciferase expression is
caused by a short exposure to staurosporine at the beginning of
transfection (p < 0.05 for 50 and 200 nM)
observed at concentrations similar to those used to
interfere with bacterial invasion [17] and uptake of
HSPG-ligating beads [15] into HeLa cells. Notably, only
a short initial exposure to the drug (2 h) was needed to
decrease transfection efficiency 6–7-fold, suggesting that
the drug indeed affected transfection at an early stage.
The viability of cells was unaffected in these conditions as
judged by comparable MTT production in control and in
drug-treated cells (see ‘Materials and methods’).
Next, to follow these interactions, cells were transfected
with fluorescent PEI/DNA complexes. After a 1-h
incubation period cells were washed with heparin in
order to remove surface-bound complexes. Cellular
fluorescence was monitored by flow cytometry. As
shown in Figure 2, staurosporine treatment decreased the
amount of complexes internalized by HeLa cells markedly.
Again, this finding is comparable with phagocytic uptake
of HSPG-ligating beads into HeLa cells, which is blocked
by this drug [15,17], and suggests an involvement of PKC
signaling in the internalization of PEI/DNA particles.
To visualize the effect of PKC inhibition on the
intracellular distribution of complexes, HeLa cells were
transfected with fluorescent PEI/DNA complexes and
observed by confocal microscopy. The distribution of
proteoglycans in cultured epithelial cells depends on cell
density. Proteoglycans surround the cell in subconfluent
cultures but become sequestered at the basolateral surface
with the acquisition of cell polarity, as cells reach
confluence [30]. Figure 3A shows the distribution of
PEI/DNA complexes in subconfluent control transfected
cells, shortly after the onset of transfection. PEI/DNA
Figure 2. Effect of staurosporine on the cellular uptake of
PEI/DNA complexes. Cells were transfected with YOYO-1-labeled
fluorescent PEI/DNA complexes in the presence of 200 nM
staurosporine. Transfection was stopped after 1 h and cells
were analyzed by flow cytometry. Data from cells treated with
staurosporine (+drug) is superimposed on data obtained from
control (−drug). The black line corresponds to background
fluorescence obtained from non-transfected cells
complexes appear as patches over the entire cell surface.
This is consistent with previous reports on clustering of
proteoglycans, where the initial clustering is rapid and can
take place even at 4 ◦C within 5 min of incubation with
ligands [29,30]. As expected, drug treatment changes the
morphology of the cells, causing some cellular retraction
(Figure 3B). However, this treatment does not affect
the binding of PEI/DNA complexes that still appear as
patches at the cell surface in amounts comparable to
those observed for untreated cells. These observations
are compatible with an HSPG-dependent phagocytotic
process, in which staurosporine prevents internalization
at this concentration (200 nM) without affecting binding
[15,17]. Further aggregation into larger-sized clusters and
migration from the cell borders into the inner parts of the
cell are energy-dependent processes and require linkage
to the actin cytoskeleton [30]. In control cells after 3 h,
aggregates are no longer seen at the cell surface, but
appear as numerous, intracellular, bright foci in most
optical sections (Figure 3C). In striking contrast, drug-
treated cells are almost completely devoid of intracellular
complexes (Figure 3D).
Our results thus suggest that the effect of PKC inhibition
on transfection is at the receptor level, similar to the effect
of PKC inhibition on internalization of invading bacteria
or on formation of an adhesion point in response to
the extracellular matrix. In particular, the aggregation
response of the receptors taking part in transfection
is similar to the clustering response to contiguous
extracellular matrix ligands in that it appears to consist of
two successive steps; the first being rapid and independent
of PKC and the second being PKC-dependent. In a forming
adhesion point, initial patching of integrins and several
cytoskeletal proteins is observed also in the presence of
PKC inhibitors and PKC activation is required only at
a later stage to stabilize the initial associations leading
to interaction with the actin cytoskeleton [21,26]. In
fact, the similarity in the effects of staurosporine to the
inhibitory effects seen by other PKC inhibitors [26] on the
clustering response further strengthens the argument that
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Figure 3. Confocal images showing the effect of staurosporine
on binding and internalization of PEI/DNA complexes. HeLa
cells, treated with 200 nM staurosporine, were transfected
with YOYO-1-labeled fluorescent PEI/DNA complexes. (A,
B) Transfected cells, shortly after the centrifugation step,
before washing with heparin. Phase contrast images (left)
and an overlay of all 20 cellular fluorescent sections (0.4 µm
wide each, right) are shown for control cells (A) and for
staurosporine-treated cells (B). Complexes appear in the image
as bright punctuate dots. (C, D) Transfected cells at 3 h after
transfection, shown at four optical sections (out of total 41
cellular sections, 0.2 µm each), and ranked from the lower
cellular level (left) to the higher level (right). Complexes appear
as green fluorescence in the cell image for control (C) and
staurosporine-treated (D) cells
the inhibitory effects of this drug are specific (and are not
secondary effects caused by altered cell metabolism).
Earlier work has shown that cationic lipid-mediated
transfection efficiency was decreased in the presence of
cytochalasin B, an actin-polymerization inhibitor [31].
We therefore checked for a possible linkage between
transfected PEI/DNA complexes and the actin cytoskele-
ton. Integrins are not the only transmembrane receptors
responsible for linking the extracellular matrix to the
actin cytoskeleton. Recent work shows that syndecans
can also interact indirectly with actin through interac-
tions of their cytoplasmic tail with actin-binding proteins
[20,21]. In cultured epithelial cells, proteoglycans are
Figure 4. Double staining of actin and PEI/DNA complexes. HeLa
cells, transfected with Jet-PEI-FluoR-labeled PEI/DNA complexes
(N/P = 10) and stained for anti-β-actin at 3 h. (A, B) Optical
sections (0.2 µm wide) of a non-transfected HeLa cell showing
typical actin stress fibers (A) at a focal plane close to the base
(section 3/22) and cytoplasmic and cortical actin (B) deeper
(section 11/22) in the cell. (C–H) A transfected cell sectioned
at three focal planes (out of total 24 cellular sections, 0.2 µm
wide each): section 2 – close to the basal cell surface (basal),
section 10 (middle), and more apically at section 15 (upper).
The actin image (C–E) and the complex image (F–H) are shown
for each section. The localization of complexes is restricted
to a few middle sections (sections 6–11). (I) Co-localization of
complexes (red) and actin (green) in the same cell as above (at
section 7)
initially present free in the membrane, but become asso-
ciated with actin when cross-linked [28–30]. In addition,
HSPG-mediated bacterial invasion into epithelial cells has
been shown to depend on the actin cytoskeleton, both for
entry into the host cell and for intracellular transport [18].
We therefore examined the role of the actin cytoskeleton
in the uptake of PEI/DNA complexes using confocal laser
microscopy to observe complexes and microfilaments in
transfected HeLa cells. Actin was visualized using mon-
oclonal anti-β-actin conjugated to FITC, and DNA/PEI
complexes were rendered fluorescent by dilution of a
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rhodamine-conjugated PEI into 25-kDa PEI prior to com-
plexation with DNA. Optical sections of non-transfected
HeLa cells show thick, long bundles of actin filaments
(stress fibers) at the base of cells (Figure 4A) and a fine
network of thin filaments (cytoplasmic and cortical actin),
deeper within the cell (Figure 4B). The actin organization
in transfected cells at 3 h, determined by observing var-
ious focal planes (Figures 4C–4E), appears to be similar
to that of non-transfected cells, with thick fibers local-
ized to lower sections. PEI complexes are visible as a fine
punctuate fluorescence, organized in filamentous arrays
(Figures 4F-4H). These arrays are localized mainly to a
few focal planes. Such a fibrous staining pattern has
been reported previously for many HSPG ligands and
was shown to share tight co-distribution with the under-
lying actin filaments [28–30]. Comparison of the PEI
pattern with that produced by staining for actin reveals a
high degree of co-alignment (Figure 4I). PEI is clearly dis-
tributed as spots along thick, and eventually thinner, actin
filaments. In fact, cortical actin filaments seem to be better
revealed by PEI/DNA complexes than by the antibody for
β-actin (cf. Figures 4D and 4G). Interestingly, no PEI is
seen at the lowest level, at the focal plane corresponding
to the basal cell surface, which is also the most fibrous
part of the cell (cf. Figures 4C and 4F). This may be due
to the fact that proteoglycans at the basal cell surface are
simply not accessible to complexes. Alternatively, it may
indicate some functional difference between fibers at the
basal level and fibers more apically in the cell, as the
latter may represent the nascent fibers [30]. However,
whatever the exact mechanism of entry and motility, our
results point to a direct link between PEI/DNA complexes
and actin.
Finally, we found interesting mechanistic similarities
between transfection, as described above, and the
catabolism of atherogenic lipoproteins. Indeed, several
lipid particle-binding proteins including apoE also
bind HSPGs [32]. These interactions are basically
electrostatic and involve the cationic N-terminal domain
of apoE [33]. The mechanism of clearance of cationic
apoE-coated lipoprotein particles such as remnant
chylomicrons may thus be regarded, just as transfection
might be, as a diversion of anionic cell-adhesion
molecules from their initial function. Huang et al. have
exploited chylomicrons for gene delivery to the liver
[34].
In addition to involving syndecans and actin fibers
[35], endocytosis of cationic lipoprotein particles occurs
at cholesterol-rich membrane rafts [36]. To further this
parallel, we tested whether transfection was sensitive
to cholesterol depletion of the plasma membrane. As
shown in Figure 5, incubation of the cells with β-
cyclodextrin led to a dramatic dose-dependent decrease
in transfection efficiency. Indeed, cyclodextrin forms a
water-soluble inclusion complex with cholesterol and the
10 mM concentration range used is able to extract up
to 20% cholesterol from the plasma membrane without
affecting viability [36].
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Figure 5. Effect of cellular cholesterol depletion on transfec-
tion efficiency. HeLa cells were transfected (N/P = 10, 2 µg
pCMVLuc/well) in 0.5 ml serum-free medium in the presence
of increasing amounts of β-cyclodextrin. Luciferase activity
(RLU/mg cell protein± SD) was measured after 24 h
Conclusions
The above results lead us to propose the following
hypothesis for the entry of cationic complexes into
adherent cells in culture (Figure 6):
1. Electrostatic binding of the cationic
particle to syndecan HSPGs
Because virtually all adherent cultured cells express
robust levels of syndecans [37], they can take up large
amounts of DNA complexes. However, the actual amount
depends on (i) encounter with the cells: sedimentation
of large (0.2–0.5 µm) particles is more effective than
Brownian motion of small ones; large complexes can
be taken up since cell entry is not clathrin coat-
mediated. Moreover, given that the polyanionic residues
of syndecans are located at the distal end of their
extended ectodomain, interaction with particles is
possible; (ii) stability of DNA complexes during cell entry:
competitive exchange of DNA with heparan sulfates
at the cell membrane must be avoided. Exchange is
slow with cationic lipids and polymers, while a higher
critical micelle concentration or a lower polymerization
degree favors exchange, hence decreases transfection
efficiencies [4,38,39]; (iii) cell confluency should not
favor transfection since syndecan expression is either very
low in confluent fibroblast cells [40] or localized to sites
which are not accessible to the complexes in epithelial
cells [30]. Moreover, if contact-inhibited, resting cells
will restrict the access of exogeneous DNA to their
nucleus.
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Figure 6. A model for the uptake of cationic complexes by adherent cells
2. Particle-induced syndecan clustering
into cholesterol-rich rafts
‘Condensation’ of the heparan sulfates around the
cationic particles induces clustering of the extracellular
domain of syndecans (and may also prevent their
shedding). The lateral diffusion of syndecans in the
membrane plane sustains a gradual membrane zippering
around the particle. Electron microscopy supports
this view (conditions as in Ref. 2), and shows the
plasma membrane contacting the PEI/DNA particles
to closely follow their shape (Figure 6A), leading
to complementary size-adjusted intracellular vacuoles
(Figure 6C). Zippering and the absence of regular
clathrin coating are even more obvious in the case
of cationic lipid/DNA complexes (Figure 6B) where the
multilamellar lipidic phase leads to irregularly shaped
clumps with spikes.
3/4/5. Actin-mediated engulfment of
the particle
A causal link between (i) syndecan clustering as a
result of contact with an extracellular element (whether
contiguous matrix binding sites or a cationic particle),
(ii) syndecan phosphorylation, and (iii) binding to the
actin cytoskeleton has been demonstrated. The structural
link between the cytoplasmic tail of syndecans and actin,
however, is less clear and may occur through a large
variety of linker proteins including the PDZ domain and
ERM (ezrin/radixin/moesin) proteins (for review, see
[21]). This would reflect fine-tuning of the numerous
pathways in which syndecans are involved. In any case,
the constant formation of tension fibers or of a growing
network of cortical actin fibers, as suggested by the
membrane rufflings (Figures 6A and 6B), is sufficient to
pull the particle into the cell (Figure 6, step 5).
For transfection to occur, entry of large amounts
of exogeneous DNA is necessary because endosomal
escape and intracellular trafficking to the nucleus are
inefficient steps. Following syndecan-mediated cell entry,
most particles will follow the fate dictated by their coat,
i.e. vectorial transport [41] to the perinuclear lysosomal
compartment [3], the site of proteoglycan/extracellular
matrix catabolism. Escape from this common fate may
occur from time to time and will depend on the chemical
nature of the cationic vector. This is where the ‘‘finding a
needle-in-a-haystack’’ problem begins.
Binding to adhesion receptors such as integrins and
syndecans connected to actin networks thus appears to
be a very general means for particle engulfment, used by
animals (chylomicrons), by pathogens (bacteria, viruses)
or, as shown here, by cationic non-viral vectors.
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